BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the third quarter ...
XPLR Infrastructure, LP (NYSE: XIFR) today announced the pricing of the previously announced private offering of 7.750% ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈